A new study published in the Journal of the American Society of Nephrology (JASN) suggests that taking a single dose of immune system targeting antibody rituximab could lead to a five-fold decrease in relapses of a form of kidney disease for at least one year. For most children and young adults with a kidney disorder called idiopathic nephrotic syndrome (INS), the disease is thought to arise from an abnormal immune response. Researchers have shown that the drug ...
Read More
No comments:
Post a Comment